RPRX

39.73

0.35% 0.14

Dopo l'orario di chiusura: 39.70 -0.03 -0.08%

Royalty Pharma Plc (RPRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$39.59

Aprire:

$39.5

Volume 24 ore:

5.13M

Relative Volume:

1.24

Capitalizzazione di mercato:

$17.18B

Reddito:

$2.31B

Utile/perdita netta:

$1.66B

Rapporto P/E:

17.30

EPS:

2.297

Flusso di cassa netto:

$827.02M

1 W Prestazione:

-2.57%

1M Prestazione:

+12.10%

6M Prestazione:

+21.05%

1 anno Prestazione:

+53.69%

Intervallo 1D:

$39.38

$40.01

Intervallo di 1 settimana:

$38.39

$40.10

Portata 52W:

$24.05

$41.24

Royalty Pharma Plc Stock (RPRX) Company Profile

Nome

Royalty Pharma Plc

Settore

Healthcare (1103)

Industria

Biotechnology (618)

Telefono

(212) 883-0200

Indirizzo

110 EAST 59TH STREET, NEW YORK, NY

Dipendente

Cinguettio

Prossima data di guadagno

2025-02-11

Ultimi documenti SEC

RPRX's Discussions on Twitter

Confronta RPRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
RPRX Royalty Pharma Plc	39.73	16.91B	2.31B	1.66B	827.02M	2.297
VRTX Vertex Pharmaceuticals Inc	434.52	110.16B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	694.99	71.65B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	453.97	59.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	891.73	54.79B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	368.36	41.77B	4.98B	69.59M	525.67M	0.5197

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-30	Iniziato	Goldman	Buy
2025-05-16	Iniziato	Morgan Stanley	Overweight
2024-06-03	Downgrade	UBS	Buy → Neutral
2022-06-14	Ripresa	UBS	Buy
2022-05-13	Iniziato	Scotiabank	Sector Outperform
2022-04-27	Iniziato	Goldman	Buy
2022-04-14	Aggiornamento	JP Morgan	Neutral → Overweight
2022-04-06	Ripresa	Morgan Stanley	Overweight
2021-10-29	Aggiornamento	Citigroup	Neutral → Buy
2021-07-30	Iniziato	Tigress Financial	Buy
2020-11-09	Aggiornamento	UBS	Neutral → Buy
2020-07-14	Iniziato	Evercore ISI	In-line
2020-07-13	Iniziato	BofA Securities	Buy
2020-07-13	Iniziato	Citigroup	Neutral
2020-07-13	Iniziato	Cowen	Outperform
2020-07-13	Iniziato	Goldman	Neutral
2020-07-13	Iniziato	JP Morgan	Neutral
2020-07-13	Iniziato	Morgan Stanley	Equal-Weight
2020-07-13	Iniziato	SunTrust	Buy
2020-07-13	Iniziato	UBS	Neutral

Mostra tutto

Royalty Pharma Plc Borsa (RPRX) Ultime notizie

Nov 13, 2025

Analyzing net buyer seller activity in Royalty Pharma plcTrade Volume Report & High Conviction Trade Alerts - newser.com

Nov 13, 2025

Will Royalty Pharma plc (RPD) stock hit Wall Street targets2025 Buyback Activity & Consistent Profit Alerts - newser.com

Nov 13, 2025

Historical volatility pattern of Royalty Pharma plc visualizedJuly 2025 Short Interest & Long-Term Growth Plans - newser.com

Nov 13, 2025

Can Royalty Pharma plc stock rebound after recent weaknessShare Buyback & Daily Oversold Bounce Ideas - newser.com

Nov 13, 2025

Jupiter Asset Management Ltd. Acquires 1,380,115 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Nov 13, 2025

Why analysts remain bullish on Royalty Pharma plc stockMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com

Nov 13, 2025

Nov 12, 2025

Is Royalty Pharma plc reversing from oversold territoryWeekly Volume Report & Step-by-Step Swing Trade Plans - newser.com

Nov 12, 2025

Is Royalty Pharma plc (RPD) stock attractive post correctionMarket Activity Report & Weekly Breakout Stock Alerts - newser.com

Nov 12, 2025

Ex-Dividend Reminder: Royalty Pharma, Cencora and MMM - Nasdaq

Nov 12, 2025

Will Royalty Pharma plc (RPD) stock maintain strong growthDip Buying & Safe Swing Trade Setups - newser.com

Nov 12, 2025

Bank of New York Mellon Corp Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Nov 12, 2025